Liver - Original Article

Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study

Volume 30 · Issue 3 Publish Date: July 25, 2019
Full Text PDF
DOI
Meryem Demir
Department of Internal Medicine Marmara University School of Medicine İstanbul Turkey
Oğuzhan Deyneli
Department of Endocrinology and Metabolism Marmara University School of Medicine İstanbul TurkeyDepartment of Endocrinology and Metabolism Koç University School of Medicine İstanbul Turkey
Yusuf Yılmaz
Department of Gastroenterology Marmara University School of Medicine İstanbul TurkeyInstitute of Gastroenterology Marmara University İstanbul Turkey
Demir, M., Deyneli, O., & Yılmaz, Y. (2019). Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study. Turkish Journal of Gastroenterology, 30(3), 266–270. https://doi.org/10.5152/tjg.2018.18559
Full Text PDF

Abstract

Background/Aims: Non-alcoholic fatty liver disease is highly prevalent in patients with type 2 diabetes mellitus (T2DM). The aim of the present study was to investigate the potential usefulness of transient elastography (TE), which is a technique that allows measuring both fibrosis and liver fat content simultaneously, as a screening tool for hepatic involvement in Turkish patients with T2DM. Materials and Methods: We obtained liver stiffness measurements (LSMs, as a measure of fibrosis) and controlled attenuation parameter (CAP, as a marker of steatosis) in 124 (46 males and 78 females; mean body mass index (BMI): 33.2±6.6 kg/m2) Turkish patients with T2DM. The prevalence rates of overweight, obesity, and metabolic syndrome in our sample were 28.2%, 64.5%, and 77.4%, respectively. Probe-specific LSM cut-off values were used to define advanced fibrosis (≥F3) and cirrhosis (F4) (M probe: F3=9.6-11.4 kPa, F4 ≥11.5 kPa and XL probe: F3=9.3-10.9 kPa, F4 ≥11.0 kPa). Mild, moderate, and severe steatosis were defined as CAP 222-232 dB/m, CAP 233-289 dB/m, and CAP ≥290 dB/m, respectively. Results: Advanced fibrosis and cirrhosis were identified in 21 (16.9%) and 10 (8.0%) patients, respectively. TE-defined hepatic steatosis (CAP>222 dB/m) was detected in 117 (94.3%) patients. Mild, moderate, and severe steatosis were identified in 0, 29, and 88 patients, respectively. Conclusion: TE is a useful non-invasive imaging modality to screen for liver involvement in Turkish patients with T2DM. High rates of TE-defined fibrosis and steatosis in our sample reflect the presence of an elevated mean BMI. Cite this article as: Demir M, Deyneli O, Yılmaz Y. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study. Turk J Gastroenterol 2019; 30(3): 266-70.

Most read articles by the same author(s)

1 2 > >> 
Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 30 · Issue 3
Pages 266-270
History
Published Online July 25, 2019
Copyright
Affiliations
Meryem Demir
Department of Internal Medicine Marmara University School of Medicine İstanbul Turkey
Oğuzhan Deyneli
Department of Endocrinology and Metabolism Marmara University School of Medicine İstanbul TurkeyDepartment of Endocrinology and Metabolism Koç University School of Medicine İstanbul Turkey
Yusuf Yılmaz
Department of Gastroenterology Marmara University School of Medicine İstanbul TurkeyInstitute of Gastroenterology Marmara University İstanbul Turkey
Cite this Article
Demir, M., Deyneli, O., & Yılmaz, Y. (2019). Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study. Turkish Journal of Gastroenterology, 30(3), 266–270. https://doi.org/10.5152/tjg.2018.18559
Outlines